Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

RecruitingOBSERVATIONAL
Enrollment

450

Participants

Timeline

Start Date

January 22, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

January 31, 2034

Conditions
Rheumatoid ArthritisInterstitial Lung Disease
Interventions
GENETIC

Research Testing Performed (Laboratory)

Blood collection (DNA, RNA)

DIAGNOSTIC_TEST

Information Collected as Standard of Care

High Resolution CT Scan (Chest), Pulmonary Function Testing (PFT), 6-Minute Walk Test (6MWT)

OTHER

Research Testing Performed

Blood collection (non-genetic), Buccal Swab, Rheumatologic Assessment, Pulmonary Assessment, Questionnaires

Trial Locations (4)

48109

RECRUITING

University of Michigan, Ann Arbor

66103

RECRUITING

University of Kansas, Kansas City

80045

RECRUITING

University of Colorado Denver, Aurora

94143

RECRUITING

University of California San Francisco, San Francisco

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University of California, San Francisco

OTHER

collaborator

University of Michigan

OTHER

collaborator

University of Kansas

OTHER

lead

University of Colorado, Denver

OTHER